Skip to main content

Clinical trials


Department of Health 
COVID-19: Guidance on clinical trials for institutions, HRECs, researchers and sponsors
Date: 07-Aug-2020
Audience: Research institutions, Human Research Ethics Committees, researchers and sponsors
Purpose: Guidance provides general information and advice to institutions conducting or overseeing research, Human Research Ethics Committees (HRECs), researchers and sponsors in the context of the COVID-19 pandemic.

Australian Clinical Trials Alliance (ACTA)
COVID-19 Resources for Clinical Trials​
Date: 05-May-2020
Audience: Patients, research participants, health care professionals, researchers and other staff involved in patient care and research
Purpose: Guidance on clinical trials during the COVID-19 pandemic.

Australia New Zealand Gynaecological Oncology Group (ANZGOG)​
ANZGOG & COVID-19 Statement​
Date: 31-Mar-2020
Audience: Researchers
Purpose: Statement about ANZGOG clinical trials.


FDA Oncology Center of Excellence
A message to patients with cancer and health care providers about COVID-19
Date: 21-Sep-2020
Audience: Health care providers (and patients)
Purpose: Information about oncology drug production and clinical trials.

National Cancer Institute
Coronavirus guidance
Date: 28-Aug-2020
Audience: Oncology community
Purpose: Guidance on managing clinical trials during the time of COVID-19.

US Food & Drug Administration (FDA)
FDA guidance on conduct of clinical trials of medical products during COVID-19 public health emergency
Date: 02-Jul-2020
Audience: Sponsors, clinical investigators, and institutional review boards
Purpose: Guidance to provide general considerations to assist sponsors in assuring the safety of trial participants, maintaining compliance with good clinical practice (GCP), and minimizing risks to trial integrity during the COVID-19 public health emergency.